143 related articles for article (PubMed ID: 8822945)
1. Aberrant methylation of the major breakpoint cluster region in chronic myeloid leukemia.
Litz CE; Vos JA; Copenhaver CM
Blood; 1996 Sep; 88(6):2241-9. PubMed ID: 8822945
[TBL] [Abstract][Full Text] [Related]
2. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
[TBL] [Abstract][Full Text] [Related]
3. Duplication of small segments within the major breakpoint cluster region in chronic myelogenous leukemia.
Litz CE; McClure JS; Copenhaver CM; Brunning RD
Blood; 1993 Mar; 81(6):1567-72. PubMed ID: 8453102
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML.
Mills KI; Sproul AM; Burnett AK
Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349
[TBL] [Abstract][Full Text] [Related]
5. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.
Grossman A; Silver RT; Arlin Z; Coleman M; Camposano E; Gascon P; Benn PA
Am J Hum Genet; 1989 Nov; 45(5):729-38. PubMed ID: 2683759
[TBL] [Abstract][Full Text] [Related]
6. DNA sequence analysis of the major breakpoint cluster region of the BCR gene rearranged in Philadelphia-positive human leukemias.
Sowerby SJ; Kennedy MA; Fitzgerald PH; Morris CM
Oncogene; 1993 Jun; 8(6):1679-83. PubMed ID: 8502487
[TBL] [Abstract][Full Text] [Related]
7. Paternal origin of the rearranged major breakpoint cluster region in chronic myeloid leukemia.
Litz CE; Copenhaver CM
Blood; 1994 Jun; 83(12):3445-8. PubMed ID: 8204872
[TBL] [Abstract][Full Text] [Related]
8. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
[TBL] [Abstract][Full Text] [Related]
10. BCR gene recombines with genomically distinct sites on band 11Q13 in complex BCR-ABL translocations of chronic myeloid leukemia.
Morris C; Jeffs A; Smith T; McDonald M; Board P; Kennedy M; Fitzgerald P
Oncogene; 1996 Feb; 12(3):677-85. PubMed ID: 8637725
[TBL] [Abstract][Full Text] [Related]
11. A new chromosomal breakpoint in Ph positive, bcr negative chronic myelogenous leukemia. Report of a case.
Negrini M; Tallarico A; Pazzi I; Castagnoli A; Cuneo A; Castoldi GL
Cancer Genet Cytogenet; 1992 Jul; 61(1):11-3. PubMed ID: 1353407
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic response to alpha-interferon is predicted in early chronic phase chronic myeloid leukemia by M-bcr breakpoint location.
Elliott SL; Taylor KM; Taylor DL; Rodwell RL; Williams BF; Shuttlewood MM; Wright SJ; Eliadis PE; Bunce IH; Frost TJ
Leukemia; 1995 Jun; 9(6):946-50. PubMed ID: 7596182
[TBL] [Abstract][Full Text] [Related]
13. The first BCR gene intron contains breakpoints in Philadelphia chromosome positive leukemia.
Heisterkamp N; Knoppel E; Groffen J
Nucleic Acids Res; 1988 Nov; 16(21):10069-81. PubMed ID: 3194194
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
[TBL] [Abstract][Full Text] [Related]
15. The relationship of bone marrow histology with the molecular pattern in chronic myeloid leukemia.
Vigorito AC; Lorand-Metze I; Chauffaile ML; Costa FF; Saad ST
Haematologia (Budap); 1998; 29(2):123-32. PubMed ID: 9728804
[TBL] [Abstract][Full Text] [Related]
16. Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias.
Suryanarayan K; Hunger SP; Kohler S; Carroll AJ; Crist W; Link MP; Cleary ML
Blood; 1991 Jan; 77(2):324-30. PubMed ID: 1985699
[TBL] [Abstract][Full Text] [Related]
17. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
Zion M; Ben-Yehuda D; Avraham A; Cohen O; Wetzler M; Melloul D; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10722-6. PubMed ID: 7938018
[TBL] [Abstract][Full Text] [Related]
18. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.
Eisenberg A; Silver R; Soper L; Arlin Z; Coleman M; Bernhardt B; Benn P
Leukemia; 1988 Oct; 2(10):642-7. PubMed ID: 3172841
[TBL] [Abstract][Full Text] [Related]
19. The BCR/ABL hybrid gene.
Groffen J; Heisterkamp N
Baillieres Clin Haematol; 1987 Dec; 1(4):983-99. PubMed ID: 3332859
[TBL] [Abstract][Full Text] [Related]
20. Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia.
Verschraegen CF; Talpaz M; Hirsch-Ginsberg CF; Pherwani R; Rios MB; Stass SA; Kantarjian HM
Blood; 1995 May; 85(10):2705-10. PubMed ID: 7742530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
